Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mass Screening | 6 | 2025 | 409 | 0.740 |
Why?
|
| Critical Pathways | 2 | 2024 | 16 | 0.410 |
Why?
|
| Colorectal Neoplasms | 3 | 2004 | 183 | 0.390 |
Why?
|
| Primary Health Care | 4 | 2025 | 458 | 0.280 |
Why?
|
| Sigmoidoscopy | 2 | 2004 | 13 | 0.270 |
Why?
|
| Videotape Recording | 1 | 2004 | 38 | 0.230 |
Why?
|
| Outpatients | 1 | 2025 | 80 | 0.220 |
Why?
|
| Patient Education as Topic | 2 | 2004 | 375 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 55 | 0.210 |
Why?
|
| Suicide | 1 | 2024 | 76 | 0.210 |
Why?
|
| Cognitive Dysfunction | 1 | 2025 | 236 | 0.190 |
Why?
|
| Electronic Health Records | 1 | 2024 | 238 | 0.190 |
Why?
|
| Qualitative Research | 1 | 2024 | 421 | 0.180 |
Why?
|
| Guideline Adherence | 2 | 2003 | 189 | 0.170 |
Why?
|
| Warfarin | 1 | 1999 | 71 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 65 | 0.150 |
Why?
|
| Exercise | 1 | 2024 | 767 | 0.140 |
Why?
|
| Obesity | 1 | 2024 | 970 | 0.140 |
Why?
|
| Anticoagulants | 1 | 1999 | 328 | 0.120 |
Why?
|
| Humans | 14 | 2025 | 40217 | 0.090 |
Why?
|
| Male | 8 | 2025 | 18271 | 0.080 |
Why?
|
| Female | 7 | 2025 | 20392 | 0.080 |
Why?
|
| Blood Coagulation Tests | 1 | 1989 | 4 | 0.080 |
Why?
|
| Prothrombin Time | 1 | 1989 | 5 | 0.080 |
Why?
|
| Partial Thromboplastin Time | 1 | 1989 | 6 | 0.080 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1989 | 26 | 0.080 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 1988 | 11 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 1988 | 49 | 0.070 |
Why?
|
| Sarcoma, Kaposi | 1 | 1988 | 14 | 0.070 |
Why?
|
| Prednisone | 1 | 1988 | 62 | 0.070 |
Why?
|
| Middle Aged | 5 | 2024 | 10090 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 10255 | 0.070 |
Why?
|
| Aged | 4 | 2025 | 8182 | 0.060 |
Why?
|
| Computers, Handheld | 1 | 2025 | 28 | 0.060 |
Why?
|
| Industry | 1 | 1985 | 60 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 1988 | 281 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 1985 | 96 | 0.050 |
Why?
|
| Universities | 1 | 1985 | 111 | 0.050 |
Why?
|
| Molecular Biology | 1 | 1985 | 62 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2024 | 75 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2025 | 203 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2025 | 1479 | 0.050 |
Why?
|
| Hospitals, Teaching | 2 | 1995 | 60 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2003 | 62 | 0.050 |
Why?
|
| Biomedical Research | 1 | 1985 | 189 | 0.050 |
Why?
|
| Liver Glycogen | 1 | 2001 | 2 | 0.040 |
Why?
|
| Hexoses | 1 | 2001 | 2 | 0.040 |
Why?
|
| Iron Chelating Agents | 1 | 2001 | 7 | 0.040 |
Why?
|
| Barium Sulfate | 1 | 2001 | 14 | 0.040 |
Why?
|
| Enema | 1 | 2001 | 8 | 0.040 |
Why?
|
| Occult Blood | 1 | 2001 | 15 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2003 | 408 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2001 | 67 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2024 | 1165 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 375 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2003 | 448 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 3141 | 0.040 |
Why?
|
| Contraindications | 1 | 1999 | 24 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2003 | 470 | 0.040 |
Why?
|
| Depression | 1 | 2024 | 608 | 0.040 |
Why?
|
| Appetite Depressants | 1 | 1998 | 4 | 0.040 |
Why?
|
| Dexfenfluramine | 1 | 1998 | 5 | 0.040 |
Why?
|
| Fenfluramine | 1 | 1998 | 5 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 1999 | 140 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 1999 | 106 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 1998 | 40 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 3136 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 600 | 0.030 |
Why?
|
| Liver | 1 | 2001 | 704 | 0.030 |
Why?
|
| Echocardiography | 1 | 1998 | 254 | 0.030 |
Why?
|
| Massachusetts | 1 | 2001 | 1701 | 0.030 |
Why?
|
| Hospital-Physician Relations | 1 | 1995 | 1 | 0.030 |
Why?
|
| Decision Making, Organizational | 1 | 1995 | 23 | 0.030 |
Why?
|
| Total Quality Management | 1 | 1995 | 45 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 1995 | 62 | 0.030 |
Why?
|
| Health Services Research | 1 | 1995 | 200 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 1998 | 1367 | 0.020 |
Why?
|
| Pennsylvania | 1 | 1989 | 38 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1989 | 62 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 1988 | 21 | 0.020 |
Why?
|
| Information Dissemination | 1 | 1985 | 84 | 0.010 |
Why?
|
| Research | 1 | 1985 | 161 | 0.010 |
Why?
|
| Culture | 1 | 2003 | 58 | 0.010 |
Why?
|
| Placebos | 1 | 2001 | 43 | 0.010 |
Why?
|
| Postprandial Period | 1 | 2001 | 16 | 0.010 |
Why?
|
| Sucrose | 1 | 2001 | 26 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 84 | 0.010 |
Why?
|
| Medicare | 1 | 2003 | 370 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 243 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2001 | 367 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 320 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2003 | 552 | 0.010 |
Why?
|
| Heart Valves | 1 | 1998 | 14 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1998 | 66 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 130 | 0.010 |
Why?
|
| Disease Progression | 1 | 1998 | 541 | 0.010 |
Why?
|
| Orthopedic Nursing | 1 | 1995 | 1 | 0.010 |
Why?
|
| Clinical Nursing Research | 1 | 1995 | 2 | 0.010 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 1995 | 7 | 0.010 |
Why?
|
| Forms and Records Control | 1 | 1995 | 13 | 0.010 |
Why?
|
| New York City | 1 | 1995 | 52 | 0.010 |
Why?
|
| New York | 1 | 1995 | 58 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 1995 | 24 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1995 | 44 | 0.010 |
Why?
|
| Case Management | 1 | 1995 | 42 | 0.010 |
Why?
|
| Diffusion of Innovation | 1 | 1995 | 52 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1995 | 108 | 0.010 |
Why?
|
| United States | 1 | 1985 | 4886 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 251 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 1995 | 102 | 0.010 |
Why?
|
| Program Evaluation | 1 | 1995 | 355 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 833 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1998 | 3138 | 0.010 |
Why?
|